Recursion Pharmaceuticals
Latest round
- Series C
Last raised
- Sep 2020
Total raised
- $427M
Investors
- 22
About Recursion Pharmaceuticals
Founded in 2013 and based in Utah, US, Recursion Pharmaceuticals, Inc. operates as a biotechnology company. The company was co-founded by CEO Chris Gibson, Blake Borgeson, and Dean Li. Recursion Pharmaceuticals, Inc. trades on the NASDAQ GS under the ticker symbol RXRX, and in May 2023, the company acquired Cyclica, and Valence. Recursion Pharmaceuticals utilizes an AI-based using machine learning robotics platform in testing various compounds on cellular disease models which helps in discovering new treatments. Recursion Pharmaceuticals combines an advanced infrastructure layer to generate proprietary biological and chemical datasets and the Recursion Map, a suite of custom software, algorithms, and machine learning tools that the company uses to explore foundational biology and navigate to new biological insights.
Who invested in Recursion Pharmaceuticals
22 investors across 5 rounds
See all investors in Recursion Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Recursion Pharmaceuticals
Who invested in Recursion Pharmaceuticals?
Recursion Pharmaceuticals has 22 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Recursion Pharmaceuticals raised?
Recursion Pharmaceuticals has raised 5 venture rounds. Sign up free to see how much each round raised and the total.
When did Recursion Pharmaceuticals last raise money?
Recursion Pharmaceuticals's most recent round on record is a Series C, in Sep 2020.
What does Recursion Pharmaceuticals do?
Founded in 2013 and based in Utah, US, Recursion Pharmaceuticals, Inc.
Where is Recursion Pharmaceuticals headquartered?
Recursion Pharmaceuticals is headquartered in Salt Lake City, US.
Which VCs invest in companies like Recursion Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back software companies at Recursion Pharmaceuticals's stage. Their profiles are linked below.
VCs backing software startups at Series C
Raising like Recursion Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.